IOVA
Iovance Biotherapeutics Inc
12.90$
-0.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.57 | 0.74 | |
| – | 0.00 | – | 25.42 | 0.00 | 0.48 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.07 | 0.06 | 0.09 | 0.13 | 0.05 | 0.43 | 0.02 | |
| – | – | – | -25.42 | 0.00 | -0.48 | -0.37 | -0.02 | -0.02 | -0.01 | -0.01 | -0.07 | -0.06 | -0.09 | -0.13 | -0.04 | 0.14 | 0.72 | |
| – | – | – | 2.31 | 2.07 | 0.14 | 0.11 | 0.35 | 0.51 | 1.10 | 1.03 | 1.34 | 1.46 | 1.69 | 1.85 | 1.46 | 0.97 | 0.84 | |
| 0.02 | 0.02 | 1.16 | 25.42 | 8.11 | 0.48 | 0.37 | 0.28 | 0.46 | 0.33 | 0.29 | 0.33 | 0.44 | 0.55 | 0.65 | 0.12 | 0.18 | 0.43 | |
| 0.05 | 0.02 | 1.25 | 2.52 | 10.18 | 1.84 | 0.11 | 0.63 | 0.97 | 1.42 | 1.32 | 1.66 | 1.89 | 2.23 | 2.50 | 1.92 | 1.50 | 1.85 | |
| -0.05 | -0.02 | -1.25 | -27.95 | -10.18 | -2.32 | -0.48 | -0.63 | -0.97 | -1.42 | -1.32 | -1.66 | -1.89 | -2.23 | -2.50 | -1.96 | -1.36 | -1.13 | |
| 0.00 | 0.00 | 0.00 | 0.20 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.02 | – | – | – | |
| -0.05 | -0.02 | -2.46 | -33.84 | -4.14 | -2.60 | -0.48 | -0.62 | -0.96 | -1.41 | -1.27 | -1.59 | -1.88 | -2.23 | -2.49 | -1.90 | -1.29 | -1.10 | |
| – | – | 1.21 | 6.11 | 0.00 | 0.05 | 0.00 | -0.02 | -0.02 | -0.01 | 0.05 | -0.08 | -0.02 | -0.09 | -0.04 | -0.01 | -0.01 | -0.01 | |
| -0.05 | -0.02 | -2.46 | -33.84 | -4.14 | -2.60 | -0.48 | -0.62 | -0.96 | -1.41 | -1.27 | -1.50 | -1.88 | -2.14 | -2.45 | -1.89 | -1.28 | -1.09 | |
| -0.05 | -0.02 | -2.37 | -27.05 | -10.18 | -2.55 | -0.48 | -0.60 | -0.95 | -1.41 | -1.31 | -1.65 | -1.89 | -2.14 | -2.37 | -1.76 | -1.14 | -1.00 |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.